中国成人系统性自身炎症性疾病的表型与基因型特征
该前瞻性研究纳入2015年4月至2017年10月北京协和医院成人SAIDs中心92例疑似SAIDs的成人患者(≥16岁),最终50例确诊,包括FMF、NLRP12-AID、NLRP3-AID、TRAPS、Blau综合征、YAOS和PFAPA。30例成年起病,诊断延迟中位时间9年,成人单基因SAIDs多携带低外显率突变且均为杂合或复合杂合。中国成人SAIDs临床表现频率与其他国家成人相似,但与儿科人群不同。
要点
- FMF、NLRP3-AID和NLRP12-AID是中国成人相对常见的单基因SAIDs。
- 成人起病SAIDs可能与低外显率突变相关,表现不典型导致诊断延迟。
- 成人单基因SAIDs基因变异均为杂合或复合杂合,未提及纯合突变。
核心结论
- FMF、NLRP3-AID和NLRP12-AID是中国成人相对常见的单基因SAIDs。
- 成人起病SAIDs可能与低外显率突变相关,表现为非特异性、不完全或不典型疾病模式,导致诊断延迟。
研究设计与样本
- 前瞻性评估2015年4月至2017年10月北京协和医院成人SAIDs中心92例疑似SAIDs的成人患者(≥16岁)的临床和遗传特征。
- 每例疾病的确诊需同时满足临床表型和基因确认。
- 将患者临床表现与儿科人群及其他国家患者进行比较。
主要发现
- 最终50例确诊SAIDs,包括13例FMF、10例NLRP12-AID、7例NLRP3-AID、5例TRAPS、3例Blau综合征、3例YAOS和9例PFAPA。
- 30例患者成年起病,最终诊断延迟中位时间为9年。
- 成人单基因SAIDs患者通常携带低外显率突变,所有基因变异均为杂合或复合杂合。
- 中国成人SAIDs患者临床表现频率与其他国家成人患者相似,但与儿科人群不同。
关键数值与推荐
- 确诊标准:同时满足临床表型和基因确认。
- 成人起病:30例患者首次发病在成年期。
- 诊断延迟:中位时间9年。
- 基因变异:所有变异均为杂合或复合杂合。
临床怎么用
- 对疑似SAIDs的成人患者应进行临床表型评估和基因检测以确诊。
- 成人起病SAIDs表现可能不典型,需警惕诊断延迟。
- 中国成人SAIDs的疾病谱与儿科不同,应参考成人数据。
局限性
- 单中心研究,样本量有限(92例疑似,50例确诊)。
- 研究期间为2015年4月至2017年10月,可能存在时间限制。
- 未提及长期随访数据或治疗反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to characterize the phenotypes and genotypes of Chinese adult patients with systemic autoinflammatory diseases (SAIDs). METHODS: We prospectively evaluated clinical and genetic features of 92 adult patients (≥16 years) suspected of SAIDs in the period from April 2015 to October 2017, at the adult SAIDs center, Peking Union Medical College Hospital. The definite diagnosis of each disease was deemed to be present if both clinical phenotypes and genetic confirmation were met. Clinical manifestations of these patients were compared with those from the pediatric populations and patients from other countries. RESULTS: A final diagnosis of SAIDs was reached in 50 patients, including 13 familial Mediterranean fever (FMF), 10 NLRP12-associated autoinflammtory disease (NLRP12-AID), 7 NLRP3-associated autoinflammatory disease (NLRP3-AID), 5 tumor necrosis factor receptor-associated periodic fever syndrome (TRAPS), 3 Blau syndrome, 3 Yao syndrome (YAOS) and 9 periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA). First disease onset during adulthood was observed in 30 patients, and the final diagnosis was delayed with a median time of 9 years. Adult monogenic SAIDs patients usually carried low-penetrance mutations and all gene variants were presented as heterozygosis or compound heterozygosis. Frequencies of clinical manifestations in Chinese adult SAIDs patients were similar with adult patients in other countries, but different from pediatric populations. CONCLUSIONS: FMF, NLRP3-AID, and NLRP12-AID are relatively common monogenic SAIDs in Chinese adults. Adult-onset SAIDs may be related to the presence of low-penetrance mutations, characterized by nonspecific, incomplete or atypical disease patterns compared with child-onset SAIDs, leading to a delay of diagnosis.
引用
- Hua Y, Wu D, Shen M, et al. Phenotypes and genotypes of Chinese adult patients with systemic autoinflammatory diseases. Semin Arthritis Rheum. 2019. PMID: 31155445. doi:10.1016/j.semarthrit.2019.05.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。